FRES
Fresh2 Group Ltd
NASDAQ: FRES · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.85
+0.00% today
Updated 2026-04-30
Market cap
$2.97M
P/E ratio
—
P/S ratio
0.12x
EPS (TTM)
$-72.68
Dividend yield
—
52W range
$0 – $0
Volume
0.3M
Fresh2 Group Ltd (FRES) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Operating cash flow | $-48.47M | $-55.75M | $-70.78M | $-55.06M |
| Capital expenditures | $3.15M | $2.36M | $3.92M | $1.59M |
| Depreciation | — | — | — | — |
| Stock-based comp | $226.41M | $115.91M | $217.50M | $14.92M |
| Free cash flow | $-51.62M | $-58.10M | $-74.70M | $-56.65M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |